Trump’s first 100 days tout US-bound pharma investments amid tariff worries
Pharma companies are looking to shore up manufacturing operations in the US to counter international tariffs, but are also bracing…
All articles by Manasi Vaidya
Manasi Vaidya
@manasivaidya22
Manasi Vaidya is an editor for GlobalData Insights where she covers the healthcare space. She writes and edits features that look at the research, regulation and reimbursement of drugs with a focus on topics at the intersection of business and science.
-
-
Podcast: What’s next for pharma tariffs?
The US government has signalled a major shift in its trade policies in recent weeks, with several announcements detailing plans…
-
Eli Lilly targets Scorpion Therapeutics to expand reach in oncology
Eli Lilly will buy Boston biotech Scorpion Therapeutics’ PI3Kα inhibitor for upto $2.5bn in cash, with the latter splitting away…
-
Trump picks vaccine sceptic RFK Jr to lead HHS in new administration
President-elect Donald Trump has appointed Robert F Kennedy Jr, popularly known as RFK Jr, as the secretary of the premier…
-
Magazine: UK’s new Netflix-style funding model for antibiotics goes live
After trialling a subscription-style system for procuring antimicrobial drugs, the UK’s National Health Service recently announced that it will formalise…
-
European pharma regulation changes signal tumult and transformation
The ongoing European Union (EU) elections, a revision of key legislation governing the pharmaceutical and biotech industry in Europe, and…
-
Data needed to forge the link between AI and mRNA
Tackling two of the buzziest trends in pharma right now; AI and mRNA therapeutics, is high on the agenda of…
-
FDA hearing set to discuss advisory committee members’ conflicts and more
An upcoming session designed to gather suggestions to optimise the US Food and Drug Administration (FDA) Advisory Committee (AdCom) meetings…
-
Magazine: Anticipation rises for RSV rollout as positive data emerges
The last year was a momentous one for RSV research with more than one vaccine and a new treatment for…
-
Magazine: What’s next for AAV gene therapies in 2024?
As the number of specialised gene therapies continues to grow in the biotech sector, one particular subtype— those using adeno-associated…